Literature DB >> 2166094

Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency.

V T Innanen1, J M Vale.   

Abstract

Attenuated or partial 21-hydroxylase deficiency is one of several biochemical defects in steroid metabolism that can lead to hirsutism in young women after puberty. The diagnosis is made through the exaggerated response of 17 alpha-hydroxyprogesterone (17-OH) to adrenocorticotrophic hormone (ACTH). To provide reference data 72 mild to moderately hirsute patients aged 18 to 35 were studied (over two years) with the ACTH test. Four patients with an exaggerated response were found. The mean (+/- 1SD) for zero time was 2.4 (0.96) nmol/l and for the 60 minute time was 7.2 (2.04) nmol/l. A subpopulation was found with a significantly higher baseline at 6.2 (1.3) nmol/l but a blunted 60 minute response at 8.7 (2.5) nmol/l. This is important because of the potential confusion arising from the known variability in baseline values in previously reported patients with partial 21-hydroxylase deficiency. Extending the test to 90 minutes did not show further increase in the 17-OH response to ACTH, thus confirming the validity of the 60 minutes ACTH test. The cortisol response to ACTH was also studied. One patient with presumptive partial 21-hydroxylase deficiency overlapped in cortisol response with eight of the reference population. Theoretically, a blunted cortisol response would be expected because of the postulated enzyme block, and these results suggest that other steroid enzyme defects should also be considered when an exaggerated 17-OH response to ACTH is seen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166094      PMCID: PMC502504          DOI: 10.1136/jcp.43.6.493

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.

Authors:  S Y Pang; A J Lerner; E Stoner; L S Levine; S E Oberfield; I Engel; M I New
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

Review 2.  Pathogenesis and treatment of polycystic ovary syndrome.

Authors:  T J McKenna
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

3.  Validation of procedure for setting normal limits on basis of total laboratory experience.

Authors:  W R Best; C C Mason; S S Barron; H G Shepherd
Journal:  Clin Chim Acta       Date:  1970-04       Impact factor: 3.786

4.  Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease.

Authors:  G P Chrousos; D L Loriaux; D L Mann; G B Cutler
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

5.  Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.

Authors:  M A Kirschner; E Samojlik; E Szmal
Journal:  J Clin Endocrinol Metab       Date:  1987-10       Impact factor: 5.958

6.  Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.

Authors:  S Y Pang; B Softness; W J Sweeney; M I New
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

7.  Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency.

Authors:  A Milewicz; P Vecsei; S Korth-Schütz; D Haack; A Rösler; K Lichtwald; S Lewicka; G von Mittelstaedt
Journal:  J Steroid Biochem       Date:  1984-08       Impact factor: 4.292

8.  Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.

Authors:  R A Lobo; U Goebelsmann; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

9.  Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.

Authors:  M I New; F Lorenzen; A J Lerner; B Kohn; S E Oberfield; M S Pollack; B Dupont; E Stoner; D J Levy; S Pang; L S Levine
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

10.  Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.

Authors:  R A Lobo; U Goebelsmann
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

View more
  2 in total

Review 1.  Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal.

Authors:  C Morán; E S Knochenhauer; R Azziz
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

2.  Nonclassic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel; Ricardo Azziz
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.